Mesa Laboratories, Inc. (MLAB) stock declined over -0.80%, trading at $125.94 on NASDAQ, down from the previous close of $126.96. The stock opened at $126.98, fluctuating between $125.20 and $127.59 in the recent session.
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Employees | 736 |
Beta | 0.85 |
Sales or Revenue | $216.19M |
5Y Sales Change% | 0.605% |
Fiscal Year Ends | March |
Sector | Technology |
Industry | Hardware, Equipment & Parts |
Mesa Laboratories, Inc. (NASDAQ: MLAB) stock price is $125.94 in the last trading session. During the trading session, MLAB stock reached the peak price of $127.59 while $125.20 was the lowest point it dropped to. The percentage change in MLAB stock occurred in the recent session was -0.8% while the dollar amount for the price change in MLAB stock was -$1.02.
The NASDAQ listed MLAB is part of Hardware, Equipment & Parts industry that operates in the broader Technology sector. Mesa Laboratories, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. John V. Sakys
Vice President, Chief Financial Officer & Chief Accounting Officer
Mr. Brian David Archbold
Senior Vice President of Continuous Improvement
Mr. Peter M. Dansky
Pres of Clinical Genomics
Mr. Bryan T. Leo
Senior Vice President of Operations
Mr. Gary M. Owens
Chief Executive Officer, Pres & Director
Mr. Garrett Krushefski
Senior Vice President of Operations
MLAB's closing price is 53.22% higher than its 52-week low of $82.86 where as its distance from 52-week high of $141.17 is -10.07%.
Number of MLAB employees currently stands at 736.
Official Website of MLAB is: https://www.mesalabs.com
MLAB could be contacted at phone 303 987 8000 and can also be accessed through its website. MLAB operates from 12100 West Sixth Avenue, Lakewood, CO 80228, United States.
MLAB stock volume for the day was 7.71K shares. The average number of MLAB shares traded daily for last 3 months was 33.7K.
The market value of MLAB currently stands at $681.23M with its latest stock price at $125.94 and 5.41M of its shares outstanding.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com